Example: stock market
Value-based pricing in pharmaceuticals
requirements. The two main barriers to implementation are incompatible pricing structures and restrictive legislation: Existing pricing structure To achieve greater buying power, many countries set drug prices centrally. For example, in the UK the NHS caps spending growth on drugs via the Pharmaceutical Price Regulation Scheme (PPRS).
Download Value-based pricing in pharmaceuticals
Information
Domain:
Source:
Link to this page: